Tumor ablation finds wide application in the treatment of various types of tumors, contributing to the growth of the tumor ablation market. It is utilized in the ablation of liver, lung, kidney, bone, and prostate tumors, among others. Tumor ablation techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation, offer minimally invasive alternatives to surgery, providing precise destruction of tumor cells while preserving surrounding healthy tissue. These applications address the need for effective and localized tumor treatment, offering patients a less invasive option with reduced risks, shorter recovery time, and improved quality of life.
According to Data Bridge Market Research, the Tumor Ablation Market was valued at USD 580.1 million in 2021 and is expected to reach USD 1,591.9 million by 2029, registering a CAGR of 13.45% during the forecast period of 2022 to 2029.
“Increasing technological advancement in ablation devices facilitate market growth”
The increasing technological advancement in ablation devices drives the market for tumor ablation. Innovations such as thermal and laser ablation, irreversible electroporation, and high-intensity focused ultrasound (HIFU) have significantly contributed to the acceptance of tumor ablation methods. These advancements offer more precise and effective treatment options, improving patient outcomes and expanding applications in various cancer types. The development of these advanced ablation techniques has spurred the market's growth, as healthcare providers and patients recognize the benefits of minimally invasive and targeted therapies for tumor treatment.
What restraints the growth of the tumor ablation market?
“Infection in the liver”
Infection in the liver poses a significant restraint on the tumor ablation market. Liver infections, such as abscesses or hepatitis, can complicate the feasibility and safety of tumor ablation procedures. Infection may increase risks during the intervention, affecting patient outcomes and recovery. Additionally, the presence of disease can limit patients' eligibility for ablation therapy, impacting the potential market size. Therefore, effective infection control measures, proper patient selection, and careful assessment of the liver condition are crucial considerations to ensure the success and growth of the tumor ablation market.
Segmentation:
The tumor ablation market is segmented on the basis of type, component, deployment mode, and end user.
- On the basis of type, the tumor ablation market is segmented into tumor ablation systems, image guidance products, and accessories.
- On the basis of cancer type, the tumor ablation market is segmented into liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer, and others.
- On the basis of technology, the tumor ablation market is segmented into radiofrequency ablation, microwave ablation, cryoablation, and other technologies.
- On the basis of mode of treatment, the tumor ablation market is segmented into percutaneous ablation, laparoscopic ablation, and surgical ablation.
- On the basis of end user, the tumor ablation market is segmented into hospitals, oncology clinics and others.
Regional Insights: North America is expected to dominate the tumor ablation market
North America's dominance in the tumor ablation market can be attributed to the increasing government support for quality healthcare, which promotes the adoption of advanced treatment options. The region's high parity's purchasing power also drives market growth by facilitating access to expensive procedures and technologies.
In Asia-Pacific, the tumor ablation market is projected to experience significant growth during the forecast period. This can be attributed to a rising patient population, particularly in countries with rapidly advancing healthcare systems. The emergence of major healthcare providers in these countries further contributes to the market's growth by increasing accessibility to tumor ablation treatments and expanding healthcare infrastructure.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-tumour-ablation-market
Recent Developments
- In April 2021, Medtronic plc was granted the Breakthrough Device Designation status by the U.S. Food and Drug Administration (FDA) for its Emprint ablation catheter kit. The FDA's Breakthrough Device Program is designed to expedite patient access to innovative technologies that have the potential to enhance treatment or diagnosis of life-threatening or irreversibly debilitating conditions.
The Prominent Key Players Operating in the Tumor Ablation Market Include:
- Angio Dynamics (U.S.)
- Medtronic (Ireland)
- Boston Scientific Corporation (U.S.)
- BIOTRONIK SE & Co KG (Germany)
- EDAP TMS (France)
- HealthTronics, Inc. (U.S.)
- Misonix (U.S.)
- Medical Devices Business Services, Inc. (U.S)
- Sonacare Medical (U.S.)
- Erbe Elektromedizin GmbH (Germany)
- MERMAID MEDICAL A/S (Denmark)
- BTG International Ltd (U.K.)
- BVM Medical Limited (U.K.)
- COMSOL INC. (Sweden)
- Cortex Technology (Denmark)
- CooperSurgical, Inc. (U.S.)
- AtriCure, Inc (U.S.)
- Abbott (U.S.)
- Integra LifeSciences (U.S.)
- Smith+Nephew (U.K.)
- CONMED Corporation (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of tumor ablation market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Tumor Ablation Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
